Status:
COMPLETED
Analytical Validation of the abioSCOPE Device With a PSP Test: Point-of-Care Precision, Sample Type Comparison and Sample Stability
Lead Sponsor:
University Hospital, Limoges
Collaborating Sponsors:
Abionic SA
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Abionic SA has developed a novel point-of-care (POC) platform, the abioSCOPE, and an in vitro diagnostic kit for the quantification of the pancreatic stone protein (PSP) to be analyzed specifically wi...
Eligibility Criteria
Inclusion
- Provide signed and dated written informed consent by patient or close / family / trusted person prior to any mandatory study-specific procedures, sample collection, or analysis
- Male or female, 18 years of age or older;
- Hospitalized patient;
- Covered by a social security scheme.
Exclusion
- Subject suffering from a hematological pathology (coagulation disorder, severe anemia) that could interfere with the blood draw procedure;
- Subject under juridical protection.
Key Trial Info
Start Date :
April 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04797117
Start Date
April 29 2021
End Date
November 26 2021
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Limoges
Limoges, France, 87042